Oncology

Latest News
July 26th 2024

AI Model Precisely Identifies HCC Recurrence Risk Factors

July 25th 2024

Risks, Benefits of Bilateral Mastectomy for Unilateral Breast Cancer

July 24th 2024

Metabolic Dysfunction–Associated Steatotic Liver Disease Linked With CRC

July 23rd 2024

Dr Diane Mahoney Uncovers Health Disparities Among Black, Hispanic Ovarian Cancer Survivors

July 22nd 2024

Response to Immunotherapy Linked With Improved Liver Function in Advanced HCC

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Video Interviews
View All
July 25th 2024

Effective Solutions for Drug Shortages: Market Incentives, Infrastructure, and Quality Management

July 13th 2024

Lung Cancer Detection Trends Show Shift in Pandemic Aftermath

July 6th 2024

COVID-19's Potential Impact on Advanced-Stage Lung Cancer Trends

July 4th 2024

Dr Michael A. Choti: Integrated, Multidisciplinary Cancer Care Management Crucial for Value-Based Medicine

July 3rd 2024

Dr Sindhuja Kadambi: It's Time to Address the Needs of the Aging Oncology Population

July 2nd 2024

Dr Matthew Callister: Value-Based Oncology Is a Platform for Collaboration

June 11th 2024

Dr Emily Touloukian: The Power of Patient Advocacy in Community Oncology

May 29th 2024

Novel Therapy + 5-Year Bladder Preservation for Patients with NMIBC

May 29th 2024

NURE-COMBO: Patient Population, Regimen, and Efficacy in MIBC

May 14th 2024

Dr Mila Felder Discusses Promoting Well-Being Within an Organization

Podcasts
View All
April 25th 2024

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

December 19th 2023

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

August 15th 2023

Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton

March 21st 2023

Health Equity Conversations: Improving Diversity of Oncology Care Staff

February 3rd 2022

Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity

November 10th 2020

Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit

December 24th 2019

What Are the Next Steps for Collaboration, Accountability in Oncology Care First?

December 11th 2019

KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges

December 1st 2019

Podcast: This Week in Managed Care—Challenges of Rural Healthcare Delivery and Other Health News

November 10th 2019

Podcast: This Week in Managed Care—Life After the Oncology Care Model and Other Health News

More News

STS word cloud | Image Credit: Colored Lights-stock.adobe.com
July 16th 2024

Pembrolizumab Promising in Treating Soft Tissue Sarcoma

Maggie L. Shaw
Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma.
Cancer risk infographic | girafchik - stock.adobe.com
July 11th 2024

New Study Reveals 40% of US Cancer Cases, Nearly Half of Deaths Linked to Modifiable Risk Factors

Pearl Steinzor
Cigarette smoking among other modifiable risk factors were significantly associated with cancer cases and deaths.
Prescription drugs illustration | Image credit: Commonwealth Fund
July 9th 2024

FTC Finds PBMs Drive Up Drug Costs, Squeeze Out Competitors

Mary Caffrey
A long-awaited report from the Federal Trade Commission (FTC) finds that vertical integration and consolidation have worked against consumers and independent pharmacies.
Ravin Ratan, MD< MEd, MD Anderson
July 8th 2024

Caring for Patients Is a Team Sport

Maggie L. Shaw
To conclude our interview with him, Ravin Ratan, MD, MEd, of MD Anderson, explains the importance of caring for all patients and why he tries to own the process of patients feeling confident that they received the attention they deserve.
FDA Approval word blocks | Image credit: Dzmitry - stock.adobe.com
July 3rd 2024

FDA Approves FoundationOne Liquid CDx as a Diagnostic Tool for BRCA-Mutated mCRPC

Alexandra Gerlach
FoundationOne Liquid CDx can be used to identify niraparib and abiraterone acetate eligibility in patients with metastatic castration-resistant prostate cancer (mCRPC).
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network (NCCN)
July 3rd 2024

Cancer Drug Shortage: Causes, Trends, and Implications for Clinical Trials

Pearl Steinzor
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network, breaks down the causes of the ongoing cancer drug shortage, as well as its impact on clinical trials.
Combustible cigarettes vs e-cigarettes | Andrey Popov - stock.adobe.com
July 3rd 2024

Vaping and Lung Cancer Screening: Reduced Rates Among Vapers Revealed

Pearl Steinzor
e-Cigarette users may be less likely to undergo lung cancer screening, study reveals.
Group of experts | Image Credit: natali_mis-stock.adobe.com
July 3rd 2024

Experts Call for Improved Management Strategies for Dedifferentiated Liposarcoma

Maggie L. Shaw
Dedifferentiated liposarcoma is a fast-growing and more aggressive type of soft tissue sarcoma that originates as a well-differentiated sarcoma and has a typical diagnosis age of 40 to 60 years.
essica K. Paulus, ScD, Ontada
June 28th 2024

Real-World Challenges in Cancer Screening: Understanding Data Sources

Maggie L. Shaw
In part 3 of our interview, Jessica K. Paulus, ScD, Ontada, addresses the importance of understanding data sources and their impact on clinical research.
leukemia word map | Image Credit: dizain-stock.adobe.com
Published: June 28th 2024 | Updated: June 28th 2024

Infection Risk With BTK Inhibitors Low, New CLL Study Finds

Jared Kaltwasser
Only about 1% of patients with chronic lymphocytic leukemia (CLL) developed an invasive fungal infection while on a Bruton’s tyrosine kinase (BTK) inhibitor, investigators found.
Ravi Parikh, MD, MPP, assistant professor of medicine and health policy, Perelman School of Medicine, University of Pennsylvania
June 27th 2024

Evaluating Palliative Care Impact: Insights From Tennessee Oncology's OCM Participation

Mary Caffrey Pearl Steinzor
A study finds limited changes in hospice utilization, highlighting challenges in real-world implementation.
Cancer health care concept-wladimir1804-stock.adobe.com.jpeg
June 26th 2024

NCCN Survey Reveals Best Practices for Managing Cancer Drug Shortage

Pearl Steinzor
The National Comprehensive Cancer Network (NCCN) survey finds 89% of centers continue to report shortages for at least one type of systemic therapy.
representation of targeted treatment | Image Credit: Kiattisak-stock.adobe.com
June 23rd 2024

Preclinical Study Shows Promise of Dual Targeted Treatment Against TNBC

AJMC Contributor
Early findings from a new preclinical study indicate that dual blockade of aurora-A kinase and PD-L1 signaling can inhibit tumor growth in triple-negative breast cancer (TNBC), treatment for which has historically remained limited.
Interview with Jessica K. Paulus, ScD, Ontada
June 22nd 2024

Dr Jessica Paulus: Despite Treatment Advances, Progress in Lung Cancer Will Continue to Take Time

Maggie L. Shaw
“The screening victory there is going to take some more time to show its benefit at the population level,” notes Jessica K. Paulus, ScD. “Some of these things are just going to be reductions in mortality that we have to wait to observe over time.”
Hodgkin lymphoma | Image credit: Dr_Microbe - stock.adobe.com
June 18th 2024

BrECADD Regimen Reaches “Unprecedently High” PFS for Patients With Hodgkin Lymphoma

Laura Joszt, MA
The treatment regimen not only significantly improved progression-free survival (PFS) for patients with advanced stage classic Hodgkin lymphoma but was also better tolerated compared with a 20-year-old regimen being used.
Ravin Ratan, MD, MEd, MD Anderson
June 18th 2024

Treating Sarcomas With Cutting-Edge Immune Checkpoint Blockade

Maggie L. Shaw
In part 3 of an interview, MD Anderson’s Ravin Ratan, MD, MEd, discusses neoadjuvant immune checkpoint blockade for 2 specific types of soft tissue sarcomas.
Tommy Pourmahram | Image credit: McKesson
June 17th 2024

Collaborative Solutions Are Needed to Address and Mitigate America’s Drug Shortages

Tommy Pourmahram
Drug costs | Image Credit: © Cagkan - stock.adobe.com
June 17th 2024

How Thyme Care Drives Reductions in Drug Spend in the Enhancing Oncology Model

Samyukta Mullangi, MD, MBA
sarcoma | Image Credit: Dzmitry-stock.adobe.com
June 15th 2024

Key MRI Features That Likely Correlate With STS Malignancy Grades

Maggie L. Shaw
Investigators from Germany conducted a systematic review of different MRI features in soft tissue sarcoma (STS) that are used to infer tumor histological grade.
FDA Approved
June 14th 2024

Repotrectinib Approved for Use in NTRK-Positive Solid Tumors

Julia Bonavitacola
Neurotrophic tyrosine receptor kinase (NTRK)–positive locally advanced or metastatic solid tumors can now be treated with the first FDA-approved treatment option.
Human kidney cross section on scientific background | Crystal light - stock.adobe.com
June 13th 2024

Treatment-Free Survival Extended With Nivolumab/Cabozantinib in Advanced Renal Cell Carcinoma

Kyle Doherty
Nivolumab/cabozantinib combination therapy showed consistent benefits across various subgroups in patients with advanced renal cell carcinoma (RCC).
What We’re Reading: Federal Judge Blocks Florida Ban on Gender-Affirming Care; NASEM Releases Definition for Long COVID; NIH Pilot Fails to Diversify Cancer Research
June 12th 2024

What We’re Reading: Florida Ban on Gender-Affirming Care Blocked; Definition for Long COVID; NIH Pilot Fails to Diversify Cancer Research

AJMC Staff
Judge rules Florida's ban on gender-affirming care for minors unconstitutional; first consensus definition for long COVID aims to standardize diagnosis and care; pilot program for clinical trial diversity discontinued due to high cost and lack of impact.
Antibody drug conjugate in blue | huenstructurebio.com - stock.adobe.com
June 5th 2024

Antibody Drug Conjugates Show Promise in Biomarker, Prognostic Outcomes in Oncology Care

Pearl Steinzor
Posters presented at ASCO 2024 found positive responses in the prediction of tumor types and prognostic outcomes in patients with advanced solid tumors and HR+/HER2-negative (HER2–) metastatic breast cancer.
Enhertu packaging | Image credit: AstraZeneca
May 29th 2024

Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers

Ryan Flinn
Aiwu Ruth He, MD, PhD | Image credit: Medstar Health
May 27th 2024

Aiwu Ruth He, MD, PhD, Discusses 3-Year Survival Data for Durvalumab Plus Chemo in Biliary Tract Cancer, Other Advances

Interview by Mary Caffrey
what we're reading logo
May 24th 2024

What We’re Reading: Bird Flu Protective Gear; HPV Vaccine Protects Against Head, Neck Cancers; Tobacco Industry and Vapes

AJMC Staff
Many US dairy farms have not yet increased bird flu protections for employees despite the outbreak in cows; the human papillomavirus (HPV) vaccine is linked to a drastic reduction in head and neck cancers in adolescent boys and men; the World Health Organization recently accused tobacco companies of actively trying to hook a new generation on nicotine.
Natalie Dickson, MD, MMHC, FASCO, FACP | Image credit: Tennessee Oncology
May 20th 2024

Natalie Dickson, MD, MMHC, FASCO, FACP, of Tennessee Oncology Discusses Cutting-Edge Cancer Care Initiatives

Maggie L. Shaw
AHN logo | Image credit: Allegheny Health Network
May 20th 2024

AHN Cancer Institute Raises the Quality and Value Bar by Listening to Patients

Mary Caffrey
Stephen Schleicher, MD, MBA | Image credit: Tennessee Oncology
May 20th 2024

At Hearing on Recurring Cancer Drug Shortages, Rural Areas Come Into Focus

Peter Page
Bobby Reddy, MD | Image credit: Keri Tan
Published: May 20th 2024 | Updated: May 20th 2024

“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials

Mary Caffrey
12345678
...
178>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo